| þ |   | QUARTERLY      REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF      1934 |
|--------|--------|---------------------------------------------------------------------------------------------------|

| o |   | TRANSITION      REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF      1934 |
|---|--------|----------------------------------------------------------------------------------------------------|

| Delaware(State      or Other Jurisdiction ofIncorporation      or Organization) |   | 20-5013347(IRS      EmployerIdentification      No.) |
|---------------------------------------------------------------------------------|--------|------------------------------------------------------|

| Large      accelerated filer o | Accelerated      filer o  | Non-accelerated      filer o                  | Smaller      reporting company þ |
|-------------------------------------|-------------------------------------|----------------------------------------------------|--------------------------------------------|
|                                |                                | (Do      not check if a smaller reporting company) |                                       |

----

|                   |                                                                                                                                                             |   | Page   |   |
|------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------|--------|
|                   | PART      1 --- FINANCIAL INFORMATION                                                                                                                            |   |   |   |
|                   |                                                                                                                                                             |   |   |   |
| Item      1.           | Financial      Statements (unaudited)                                                                                                                            |   |   | 2      |   |
|                   | Balance Sheets                                                                                                                                                   |   |   | 2      |   |
|                   | Statements of      Operations                                                                                                                                    |   |   | 3      |   |
|                   | Statements of Stockholders’      Equity                                                                                                                    |   |   | 4      |   |
|                   | Statements of Cash      Flows                                                                                                                                    |   |   | 5      |   |
|                   | Notes to Condensed Financial      Statements                                                                                                                     |   |   | 6      |   |
|                   |                                                                                                                                                             |   |   |   |   |
| Item      2.           | Management      Discussion and Analysis of Financial Condition and Results of      Operations                                                                    |   |   | 13     |   |
|                   |                                                                                                                                                             |   |   |   |   |
| Item      3.           | Quantitative      and Qualitative Disclosure about Market Risk                                                                                                   |   |   | 15     |   |
|                   |                                                                                                                                                             |   |   |   |
| Item      4T.          | Controls      and Procedures                                                                                                                                     |   |   | 15     |   |
|                   |                                                                                                                                                             |   |   |   |   |
|                   | PART      II --- OTHER INFORMATION                                                                                                                               |   |   |   |   |
|                   |                                                                                                                                                             |   |   |   |   |
| Item      1.           | Legal      Proceedings                                                                                                                                           |   |   | 15     |   |
|                   |                                                                                                                                                             |   |   |   |
| Item      1A.          | Risk      Factors                                                                                                                                                |   |   | 16     |   |
|                   |                                                                                                                                                             |   |   |   |   |
| Item      2.           | Unregistered      Sales of Equity Securities and Use of Proceeds                                                                                                 |   |   | 16     |   |
|                   |                                                                                                                                                             |   |   |   |
| Item      3.           | Defaults      Upon Senior Securities                                                                                                                             |   |   | 16     |   |
|                   |                                                                                                                                                             |   |   |   |
| Item      4.           | Submission      of Matters to a Vote of the Security Holders                                                                                                     |   |   | 16     |   |
|                   |                                                                                                                                                             |   |   |   |
| Item      5.           | Other      Information                                                                                                                                           |   |   | 17     |   |
|                   |                                                                                                                                                             |   |   |   |   |
| Item      6.           | Exhibits                                                                                                                                                         |   |   | 18     |   |
|                   |                                                                                                                                                             |   |   |   |
| SIGNATURE              |                                                                                                                                                             |   | 19     |   |
|                   |                                                                                                                                                             |   |   |   |
| INDEX      TO EXHIBITS |                                                                                                                                                             |   | 20     |   |
|                   | Certification      by Chief Executive Officer Pursuant to Section 302                                                                                            |   |   |   |   |
|                   | Certification      by Chief Financial Officer Pursuant to Section 302                                                                                            |   |   |   |   |
|                   | Certification      by Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted      pursuant      to Section 906 of the Sarbanes-Oxley Act of 2002 |   |   |   |   |
|                   | Certification      by Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted      pursuant      to Section 906 of the Sarbanes-Oxley Act of 2002 |   |   |   |   |

----

|                                                                                                                                                      |   | March      31, 2009(Unaudited) |     |   | December      31, 2008 |       |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------------------------------|----------|--------|------------------------|------------|
|    ASSETS                                                                                                                                  |   |                           |     |   |                   |       |
|           Current      Assets                                                                           |   |                           |     |   |                   |       |
|                Cash                                                            |   | $                              | 480,438  |   |                   | $          | 801,965 |   |
|                Cash      in Trust                                              |   | ─                        |     |   |                   | 57,514,171 |   |
|                Prepaid      expense                                            |   | ─                        |     |   |                   | 33,712     |   |
|                Prepaid      federal income tax                                 |   |                           | 55,000   |   |                   |       | 55,000 |   |
|                     Total      Current Assets         |   |                           | 535,438  |   |                   |       | 58,404,848 |   |
|                                                                                                                                                      |   |                           |     |   |                   |       |   |   |
|            Fixed      Asset Net of Depreciation                                                    |   |                           | 4,598    |   |                   |       | 4,674 |   |
|                                                                                                                                                      |   |                           |     |   |                   |       |   |   |
|           TOTAL      ASSETS                                                                             |   | $                              | 540,036  |   |                   | $          | 58,409,522 |   |
|                                                                                                                                                      |   |                           |     |   |                   |       |   |   |
|    LIABILITIES      AND STOCKHOLDERS’ EQUITY                                                                                         |   |                           |     |   |                   |       |   |   |
|           Current      Liabilities                                                                      |   |                           |     |   |                   |       |   |   |
|                Accounts      payable and accrued expenses                      |   | $                              | 59,833   |   |                   | $          | 43,998 |   |
|                Due      to stockholder                                         |   | ─                        |     |   |                   | 168,794    |   |
|                Deferred      underwriting fees                                 |   | ─                        |     |   |                   | 2,133,867  |   |
|                Taxes      Payable                                              |   |                           | 1,438    |   |                   |       | 12,550 |   |
|                                                                                                                                                      |   |                           |     |   |                   |       |   |   |
|           TOTAL      LIABILITIES                                                                        |   |                           | 61,271   |   |                   |       | 2,359,209 |   |
|                                                                                                                                                      |   |                           |     |   |                   |       |   |   |
| Common      stock, subject to possible redemption, 1,949,335 shares at redemption      value, and interest subject to possible redemption                 |   | ─                        |     |   |                   | 11,178,643 |   |
|                                                                                                                                                      |   |                           |     |   |                   |       |   |   |
| COMMITMENTS                                                                                                                                               |   |                           |     |   |                   |       |   |   |
|                                                                                                                                                      |   |                           |     |   |                   |       |   |   |
|    STOCKHOLDERS’      EQUITY                                                                                                         |   |                           |     |   |                   |       |   |   |
|           Preferred      stock ─ $.0001 par value; 1,000,000 authorized;                          |   | ─                        |     |   | ─                |       |
|               0      issued and outstanding                                         |   |                           |     |   |                   |       |   |   |
|           Common      stock ─ $.0001 par value; 100,000,000 shares                                |   |                           |     |   |                   |       |   |   |
|               authorized;      2,125,000 shares issued and outstanding at March 31, |   |                           |     |   |                   |       |   |   |
|               2009;      11,876,555 issued and outstanding(which include 1,949,335  |   |                           |     |   |                   |       |   |   |
|               shares      subject to possible redemption) at December 31, 2008      |   |                           | 213      |   |                   |       | 1,188 |   |
|           Additional      paid-in capital                                                               |   | ─                        |     |   |                   | 44,074,106 |   |
|           Distribution      in excess of paid in capital                                                |   |                           | (126,580 | )      |                   | ─    |   |
|           Income      accumulated during the development stage                                          |   |                           | 605,132  |   |                   |       | 796,376 |   |
|                                                                                                                                                      |   |                           |     |   |                   |       |   |   |
|                TOTAL      SHAREHOLDERS’ EQUITY                           |   |                           | 478,765  |   |                   |       | 44,871,670 |   |
|                                                                                                                                                      |   |                           |     |   |                   |       |   |   |
|           TOTAL      LIABILITIES & STOCKHOLDERS’ EQUITY                                       |   | $                              | 540,036  |   |                   | $          | 58,409,522 |   |

----

|                                                                   |   |                    |      |   |                    |   |       | Period      from                        |   |
|------------------------------------------------------------------------|--------|-------------------------|-----------|--------|-------------------------|--------|------------|-----------------------------------------|--------|
|                                                                   |   |                    |      |   |                    |   |       | June      7, 2006                       |   |
|                                                                   |   | Three      Months Ended |      |   | Three      Months Ended |   |       | (inception)      to March      31, 2009 |   |
|                                                                   |   | March      31, 2009     |      |   | March      31, 2008     |   |       | (Cumulative)                            |   |
| Interest      Income                                                   |   | $                       | 1,113     |   |                    | $      | 297,841    |                                    |   | $ | 2,584,534 |   |
|                                                                   |   |                    |      |   |                    |   |       |                                    |   |   |   |   |
| Formation      and operating costs                                     |   |                    | 190,119   |   |                    |   | 257,293    |                                    |   |   | 1,371,345 |   |
| Delaware      franchise tax                                            |   |                    | 1,438     |   |                    |   | 15,688     |                                    |   |   | 128,134 |   |
|                                                                   |   |                    |      |   |                    |   |       |                                    |   |   |   |   |
| Income      (loss) before provision for income taxes                   |   |                    | (190,444  | )      |                    |   | 24,860     |                                    |   |   | 1,085,055 |   |
|                                                                   |   |                    |      |   |                    |   |       |                                    |   |   |   |   |
| Provision      for income taxes                                        |   |                    | 800       |   |                    |   | 8,980      |                                    |   |   | 479,923 |   |
|                                                                   |   |                    |      |   |                    |   |       |                                    |   |   |   |   |
| Net      income(loss)                                                  |   | $                       | (191,244  | )      |                    | $      | 15,880     |                                    |   | $ | 605,132 |   |
| Net      income (loss) per share (basic and diluted)                   |   | $                       | (0.02     | )      |                    | $      | 0.00       |                                    |   | $ | 0.07 |   |
|                                                                   |   |                    |      |   |                    |   |       |                                    |   |   |   |   |
| Weighted      average number of shares outstanding (basic and diluted) |   |                    | 9,059,439 |   |                    |   | 11,876,555 |                                    |   |   | 8,701,763 |   |

----

|                                                                                 |   |              |       |   |                   |    |    |                                   |    |        |  Income      (deficit)    |   |     |    |     |
|--------------------------------------------------------------------------------------|--------|-------------------|------------|--------|------------------------|---------|---------|----------------------------------------|---------|-------------|--------------------------------|--------|----------|---------|----------|
|                                                                                 |   | Common      Stock |       |   |        Additional |    |    |  accumulated      during      the |    |        | Total      Stockholders’ |   |
|                                                                                 |   | Shares            |       |   | Amount                 |    |    | paid-in      Capital                   |    |        | development      stage         |   |     | Equity  |     |
| Issuance      of common stock to founders and                                        |   |              |       |   |                   |    |    |                                   |    |        |                           |   |     |    |     |
| insiders      on June 7, 2006 at $.01 per share                                      |   |              | 2,500,000  |   |                   | $       | 250     |                                   |    | $           | 24,750                         |   |     | $       | ─  |   |   | $ | 25,000 |   |
| Net      Loss                                                                        |   |              |       |   |                   |    |    |                                   |    |        |                           |   |     |    | (3,000   | ) |   |   | (3,000 | ) |
| Balance      at December 31, 2006                                                    |   |              | 2,500,000  |   |                   |    | 250     |                                   |    |        | 24,750                         |   |     |    | (3,000   | ) |   |   | 22,000 |   |
| Surrender      and cancellation of 375,000 shares                                    |   |              |       |   |                   |    |    |                                   |    |        |                           |   |     |    |     |   |   |   |   |   |
|    of      common stock by initial stockholders on                    |   |              |       |   |                   |    |    |                                   |    |        |                           |   |     |    |     |   |   |   |   |   |
|    January      24, 2007                                              |   |              | (375,000   | )      |                   |    | (37     | )                                      |    |        | 37                             |   |     |    | ─  |   |   |   | ─ |   |
| Sale      of 3,000,000 private placement warrants                                    |   |              |       |   |                   |    |    |                                   |    |        |                           |   |     |    |     |   |   |   |   |   |
|    to      the Chairman of the Board of Directors on                  |   |              |       |   |                   |    |    |                                   |    |        |                           |   |     |    |     |   |   |   |   |   |
|    April      25, 2007                                                |   |              | ─    |   |                   |    | ─ |                                   |    |        | 1,500,000                      |   |     | ─ |     |   |   | 1,500,000 |   |
| Sale      of 8,500,000 units, net of underwriters                                    |   |              |       |   |                   |    |    |                                   |    |        |                           |   |     |    |     |   |   |   |   |   |
|    discount      and offering expenses (1,699,150                     |   |              |       |   |                   |    |    |                                   |    |        |                           |   |     |    |     |   |   |   |   |   |
|    shares      subject to possible redemption)                        |   |              |       |   |                   |    |    |                                   |    |        |                           |   |     |    |     |   |   |   |   |   |
|    on      April 25, 2007                                             |   |              | 8,500,000  |   |                   |    | 850     |                                   |    |        | 46,407,199                     |   |     | ─ |     |   |   | 46,408,049 |   |
| Proceeds      from issuance of underwriter’soption                             |   |              | ─    |   |                   | ─ |    |                                   |    | 100         |                           |   | ─  |    |     |   | 100 |   |
| Sale      of 1,251,555 units, underwriter’s over-                              |   |              |       |   |                   |    |    |                                   |    |        |                           |   |     |    |     |   |   |   |   |   |
|    allotment      option, net of underwriter’s    discount      |   |              |       |   |                   |    |    |                                   |    |        |                           |   |     |    |     |   |   |   |   |   |
|   (250,185      shares subject to possible redemption) on      May 9, 2007 |   |              | 1,251,555  |   |                   |    | 125     |                                   |    |        | 7,171,285                      |   |     | ─ |     |   |   | 7,171,410 |   |
| Proceeds      subject to possible redemption                                         |   |              |       |   |                   |    |    |                                   |    |        |                           |   |     |    |     |   |   |   |   |   |
|    of      1,949,335 shares                                           |   |              | ─    |   |                   | ─ |    |                                   |    | (11,029,265 | )                              |   | ─  |    |     |   | (11,029,265 | ) |
| Net      income for 2007                                                             |   |              | ─    |   |                   | ─ |    |                                   | ─ |        |                           |   | 918,210  |    |     |   | 918,210 |   |
|    Balance      at December 31, 2007                                  |   |              | 11,876,555 |   |                   | $       | 1,188   |                                   |    | $           | 44,074,106                     |   |     | $       | 915,210  |   |   | $ | 44,990,504 |   |
|                                                                                 |   |              |       |   |                   |    |    |                                   |    |        |                           |   |     |    |     |   |   |   |   |   |
| Net      loss for 2008                                                               |   |              | ─    |   |                   | ─ |    |                                   | ─ |        |                           |   | (118,834 | )       |     |   | (118,834 | ) |
|    Balance      at December 31, 2008                                  |   |              | 11,876,555 |   |                   | $       | 1,188   |                                   |    | $           | 44,074,106                     |   |     | $       | 796,376  |   |   | $ | 44,871,670 |   |
| Unaudited:                                                                           |   |              |       |   |                   |    |    |                                   |    |        |                           |   |     |    |     |   |   |   |   |   |
| Cancellation      of public Common Stock due to                                      |   |              | (9,751,555 | )      |                   |    | (975    | )                                      |    |        | 975                            |   |     | ─ |     |   | ─ |   |
| distribution      of Trust Funds                                                     |   |              | ─    |   |                   |    | ─ |                                   |    |        | (57,514,171                    | )      |     | ─ |     |   |   | (57,514,171 | ) |
| Cancellation      of possible redemption                                             |   |              | ─    |   |                   |    | ─ |                                   |    |        | 11,178,643                     |   |     | ─ |     |   |   | 11,178,643 |   |
| Cancellation      of deferred Underwriter Fees                                       |   |              | ─    |   |                   |    | ─ |                                   |    |        | 2,133,867                      |   |     | ─ |     |   |   | 2,133,867 |   |
| Distribution      in excess of paid in capital                                       |   |              | ─    |   |                   |    | ─ |                                   |    |        | 126,580                        |   |     |    | (126,580 | ) |   | ─ |   |
| Net      loss for the three months ended March 31, 2009                         |   |              |       |   |                   |    |    |                                   |    |        | ─                        |   |     |    | (191,244 | ) |   |   | (191,244 | ) |
| Balance      at March 31, 2009                                                       |   |              | 2,125,000  |   |                   | $       | 213     |                                   |    | $           | ─                        |   |     | $       | 478,552  |   |   | $ | 478,765 |   |

----

|                                                                                         |   | Three      Months Ended March      31, 2009 |        |   | Three      Months Ended March      31, 2008 |     |      | Period      from June      7, 2006 (inception)      to March      31, 2009 (cumulative) |       |
|----------------------------------------------------------------------------------------------|--------|-------------------------------------------------------|-------------|--------|--------------------------------------------------|----------|-----------|-------------------------------------------------------------------------------------------------------------|------------|
| Cash      flows from operating activities:                                                   |   |                                                  |        |   |                                             |     |      |                                                                                                        |       |
|    Net      income (loss)                                                     |   | $                                                     | (191,244    | )      |                                             | $        | 15,880    |                                                                                                        |       | $ | 605,132 |   |
|    Adjustments      to reconcile net income (loss) to                         |   |                                                  |        |   |                                             |     |      |                                                                                                        |       |   |   |   |
|       net      cash used in operating activities:              |   |                                                  |        |   |                                             |     |      |                                                                                                        |       |   |   |   |
|    Depreciation                                                               |   |                                                  | 75          |   |                                             |     | 75        |                                                                                                        |       |   | 2,486 |   |
|    Changes      in:                                                           |   |                                                  |        |   |                                             |     |      |                                                                                                        |       |   |   |   |
|       Accrued      expenses                                    |   |                                                  | 15,836      |   |                                             |     | 101,328   |                                                                                                        |       |   | 59,834 |   |
|       Tax      payable                                         |   |                                                  | (11,112     | )      |                                             |     | (157,471  | )                                                                                                           |       |   | (53,562 | ) |
|       Prepaid      expense                                     |   |                                                  | 33,712      |   |                                             |     | (13,084   | )                                                                                                           |       | ─ |   |
|       Interest      earned on investment held in Trust Account |   | ─                                               |        |   |                                             | (350,814 | )         |                                                                                                        |       | (2,704,200 | ) |
|       Interest      subject to possible redemption             |   | ─                                               |        |   |                                             | 58,570   |      |                                                                                                        |       | 149,378 |   |
|                                                                                         |   |                                                  |        |   |                                             |     |      |                                                                                                        |       |   |   |   |
| Net      cash used in operating activities:                                                  |   |                                                  | (152,733    | )      |                                             |     | (345,516  | )                                                                                                           |       |   | (1,940,932 | ) |
|                                                                                         |   |                                                  |        |   |                                             |     |      |                                                                                                        |       |   |   |   |
| Cash      flows from investing activities:                                                   |   |                                                  |        |   |                                             |     |      |                                                                                                        |       |   |   |   |
|    Cash      held in Trust fund                                               |   |                                                  | 57,514,171  |   |                                             | ─  |      |                                                                                                        |       | 206,369 |   |
|    Disbursements      from trust account                                      |   |                                                  | (57,514,171 | )      |                                             |     | 450,991   |                                                                                                        |       |   | (55,016,340 | ) |
|    Purchase      fixed asset                                                  |   | ─                                               |        |   |                                             | (2,141   | )         |                                                                                                        |       | (7,085 | ) |
|                                                                                         |   |                                                  |        |   |                                             |     |      |                                                                                                        |       |   |   |   |
| Net      cash provided by (used in) investing activities:                                    |   | ─                                               |        |   |                                             | 448,850  |      |                                                                                                        |       | (54,817,056 | ) |
|                                                                                         |   |                                                  |        |   |                                             |     |      |                                                                                                        |       |   |   |   |
| Cash      flows from financing activities:                                                   |   |                                                  |        |   |                                             |     |      |                                                                                                        |       |   |   |   |
|    Proceeds      from issuance of common stock                                |   | ─                                               |        |   | ─                                          |     |      |                                                                                                        | 58,534,330 |   |
|    Proceeds      from issuance of warrants                                    |   | ─                                               |        |   | ─                                          |     |      |                                                                                                        | 1,500,000  |   |
|    Proceeds      from underwriter’s      purchase option                |   | ─                                               |        |   | ─                                          |     |      |                                                                                                        | 100        |   |
|    Proceeds      from stockholder’s      note payable                   |   | ─                                               |        |   | ─                                          |     |      |                                                                                                        | 150,000    |   |
|    Decrease      in due to stockholder                                        |   | ─                                               |        |   | ─                                          |     |      |                                                                                                        | (150,000   | ) |
|    Payment      of costs of public offering                                   |   | ─                                               |        |   | ─                                          |     |      |                                                                                                        | (2,796,004 | ) |
|    Advance      from (to) shareholders                                        |   |                                                  | (168,794    | )      |                                             |     | 1344      |                                                                                                        |       | ─ |   |
|                                                                                         |   |                                                  |        |   |                                             |     |      |                                                                                                        |       |   |   |   |
| Net      cash provided by (used in) financing activities:                                    |   |                                                  | (168,794    | )      |                                             |     | 1344      |                                                                                                        |       |   | 57,238,426 |   |
|                                                                                         |   |                                                  |        |   |                                             |     |      |                                                                                                        |       |   |   |   |
|    Net      increase (decrease) in cash                                       |   |                                                  | (321,527    | )      |                                             |     | 104,678   |                                                                                                        |       |   | 480,438 |   |
|    Beginning      balance                                                     |   |                                                  | 801,965     |   |                                             |     | 850,870   |                                                                                                        |       | ─ |   |
|                                                                                         |   |                                                  |        |   |                                             |     |      |                                                                                                        |       |   |   |   |
|    Ending      balance                                                        |   | $                                                     | 480,438     |   |                                             | $        | 955,548   |                                                                                                        |       | $ | 480,438 |   |
|                                                                                         |   |                                                  |        |   |                                             |     |      |                                                                                                        |       |   |   |   |
| Supplemental      Schedule of Non Cash Financing Activities:                                 |   |                                                  |        |   |                                             |     |      |                                                                                                        |       |   |   |   |
|    Accruals      of deferred underwriters’ fees                         |   | $                                                     | ─     |   |                                             | $        | 2,133,867 |                                                                                                        |       | $ | 2,133,867 |   |

----

----

----

----

|   | · | Acquisition      costs will be generally expensed asincurred; |
|--------|--------|---------------------------------------------------------------|

|   | · | Noncontrolling      interests (formerly known as “minority interests” — see SFAS 160      discussion below) will be valued at fair value at the acquisition      date; |
|--------|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | · | Acquired      contingent liabilities will be recorded at fair value at the acquisition      date and subsequently measured at either the higher of such amount or the      amount determined under existing guidance for non-acquired      contingencies; |
|--------|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | · | In-process      research and development will be recorded at fair value as an      indefinite-lived intangible asset at the acquisition  date; |
|--------|--------|------------------------------------------------------------------------------------------------------------------------------------------------|

|   | · | Restructuring      costs associated with a business combination will be generally expensed      subsequent to the acquisition date;and |
|--------|--------|----------------------------------------------------------------------------------------------------------------------------------------|

|   | · | Changes      in deferred tax asset valuation allowances and income tax uncertainties      after the acquisition date generally will affect income tax      expense. |
|--------|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

----

----

|                                  |   | For      the three months ended March      31, |    |
|---------------------------------------|--------|------------------------------------------------|---------|
|                                  |   | 2009                                           |    |   | 2008 |   |
| Current:                              |   |                                           |    |   |   |   |
| Federal  taxes              |   | $                                         | ─ |   |   | $ | 8,180 |   |
| State      taxes                      |   |                                           | 800     |   |   |   | 800 |   |
| Total      provision for income taxes |   | $                                              | 800     |   |   | $ | 8,980 |   |

----

----

----

Item 4. Controlsand Procedures

----

| For       |   | Against |   | Broker – Non      Votes |
|-----------|--------|---------|--------|-------------------------------|
| 6,121,293 |   | 8,580   |   | 3,016,543                     |

| For        |   | Withheld |
|------------|--------|----------|
| 11,012,921 |   | 266,595  |

| For        |   | Against |   | Abstain |
|------------|--------|---------|--------|---------|
| 11,274,116 |   | 500     |   | 4,900   |

| For       |   | Against   |   | Abstain |
|-----------|--------|-----------|--------|---------|
| 9,892,876 |   | 1,373,240 |   | 13,400  |

----

– to amend and restate the Company’s certificate ofincorporation (i) to permit the Company to continue as a corporation, beyond thetime specified without the limitations related to the Company’s IPO (ii) to remove ArticleVI from the Company’scertificate of incorporation which, among  other blank checkcompany-related restrictions, required the Company to dissolve on April 19, 2009if no qualifying business combination were consummated and (iii) to increaseauthorized shares of common stock from 50,000,0000 to 100,000,000 shares ofcommon stock.

| For       |   | Against    |   | Abstain    |
|-----------|--------|------------|--------|------------|
| 2,125,000 |   | - 0      - |   | - 0      - |

----

Item 6.Exhibits

| Number        |   | Description                                                                                                                                                                                                           |
|---------------|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 3.1           |   | Amended      and Restated Certificate of Incorporation**                                                                                                                                                              |
|          |   |                                                                                                                                                                                                                  |
| 3.1      (i)  |   | Amendment      to Certificate of Incorporation*                                                                                                                                                                       |
|          |   |                                                                                                                                                                                                                  |
| 3.1      (ii) |   | Amended      and Restated Certificate of Incorporation*                                                                                                                                                               |
|          |   |                                                                                                                                                                                                                  |
| 3.2           |   | Amended      and Restated Bylaws**                                                                                                                                                                                    |
|          |   |                                                                                                                                                                                                                  |
| 4.1           |   | Specimen      Unit Certificate**                                                                                                                                                                                      |
|          |   |                                                                                                                                                                                                                  |
| 4.2           |   | Specimen      Common Stock Certificate**                                                                                                                                                                              |
|          |   |                                                                                                                                                                                                                  |
| 4.3           |   | Specimen      Warrant Certificate**                                                                                                                                                                                   |
|          |   |                                                                                                                                                                                                                  |
| 4.5           |   | Form      of Warrant Agreement between American Stock Transfer & Trust Company      and the Registrant**                                                                                                          |
|          |   |                                                                                                                                                                                                                  |
| 4.6           |   | Form      of Underwriters’ Purchase Option**                                                                                                                                                                    |
|          |   |                                                                                                                                                                                                                  |
| 10.1(a)       |   | Letter      Agreement among the Registrant, Ferris, Baker Watts, Incorporated and Jack      Kang**                                                                                                                    |
|          |   |                                                                                                                                                                                                                  |
| 10.1(b)       |   | Letter      Agreement among the Registrant, Ferris, Baker Watts, Incorporated and      Alwin Tan**                                                                                                                    |
|          |   |                                                                                                                                                                                                                  |
| 10.1(c)       |   | Letter      Agreement among the Registrant, Ferris, Baker Watts, Incorporated and      Steven Wang**                                                                                                                  |
|          |   |                                                                                                                                                                                                                  |
| 10.1(d)       |   | Letter      Agreement among the Registrant, Ferris, Baker Watts, Incorporated and Mark      Tan**                                                                                                                     |
|          |   |                                                                                                                                                                                                                  |
| 10.1(e)       |   | Letter      Agreement among the Registrant, Ferris, Baker Watts, Incorporated and      Larry Liou**                                                                                                                   |
|          |   |                                                                                                                                                                                                                  |
| 10.1(f)       |   | Letter      Agreement among the Registrant, Ferris, Baker Watts, Incorporated and      James Ma**                                                                                                                     |
|          |   |                                                                                                                                                                                                                  |
| 10.1(g)       |   | Letter      Agreement among the Registrant, Ferris, Baker Watts, Incorporated and      Stanley Chang**                                                                                                                |
|          |   |                                                                                                                                                                                                                  |
| 10.1(h)       |   | Letter      Agreement among the Registrant, Ferris, Baker Watts, Incorporated and Ron      Harrod**                                                                                                                   |
|          |   |                                                                                                                                                                                                                  |
| 10.2          |   | Form      of Investment Management Trust Agreement between American Stock Transfer      & Trust Company and the Registrant**                                                                                      |
|          |   |                                                                                                                                                                                                                  |
| 10.3          |   | Form      of Stock Escrow Agreement between the Registrant, American Stock Transfer      & Trust Company and the Initial Stockholders**                                                                           |
|          |   |                                                                                                                                                                                                                  |
| 10.4          |   | Form      of Letter Agreement between NCIL and the Registrant regarding      administrative support**                                                                                                                 |
|          |   |                                                                                                                                                                                                                  |
| 10.5          |   | Advance      Agreement between the Registrant and Jack Kang**                                                                                                                                                         |
|          |   |                                                                                                                                                                                                                  |
| 10.6          |   | Form      of Registration Rights Agreement among the Registrant, the Initial      Stockholders and Ferris, Baker Watts, Incorporated**                                                                                |
|          |   |                                                                                                                                                                                                                  |
| 10.7          |   | Warrants      Placement Agreement**                                                                                                                                                                                   |
|          |   |                                                                                                                                                                                                                  |
| 10.8          |   | Form      of Letter Agreement between the Registrant, Jack Kang and Ferris, Baker      Watts, Incorporated**                                                                                                          |
|          |   |                                                                                                                                                                                                                  |
| 10.9          |   | Stock      Purchase Agreement among Registrant, Europe Asia Huadu Environment      Holding, Pte Ltd, Teambest International, Ltd and Wang Lahua dated      August 6, 2008***                                     |
|          |   |                                                                                                                                                                                                                  |
| 10.10         |   | Termination      Agreement dated as November 10, 2008 by and among Europe Asia Huadu      Environment Holdings, Pte Ltd, Wang Lahua, Teambest International, Ltd and      China Healthcare Acquisition Corp **** |
|          |   |                                                                                                                                                                                                                  |
| 31.1          |   | Certification      by Chief Executive Officer pursuant to Section 302 of the      Sarbanes-Oxley Act of 2002                                                                                                     |
|          |   |                                                                                                                                                                                                                  |
| 31.2          |   | Certification      by Chief Financial Officer pursuant to Section 302 of the      Sarbanes-Oxley Act of 2002                                                                                                     |

| 32.1   |   | Certification      by Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as      adopted pursuant to Section 906 of the Sarbanes-Oxley Act of      2002 |
|--------|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |   |                                                                                                                                                                       |
| 32.2   |   | Certification      by Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as      adopted pursuant to Section 906 of the Sarbanes-Oxley Act of      2002 |
|   |   |                                                                                                                                                                       |

----

| *      | Incorporated      by reference to Registrant’s Annual Report on Form 10-K/A filed on April      22, 2009                                                                               |
|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |                                                                                                                                                                                         |
| **     | Incorporated by reference to the exhibits      of the same number filed with the      Registrant’s Registration Statement on Form S-1 or amendments      thereto (File No. 333-135705) |
|   |                                                                                                                                                                                         |
| ***    | Incorporated      by reference to Registrant’s Current Report on Form 8-K filed      August 11, 2008                                                                              |
|   |                                                                                                                                                                                         |
| ****   | Incorporated      by reference to Registrant’s Current Report on Form 8-K filed      November 13, 2008                                                                            |

----

|                          | CHINA      HEALTHCARE ACQUISITION CORP. |                                             |
|-------------------------------|-----------------------------------------|--------------------------------------------------|
|                          |                                    |                                             |   |
| Date:      May 15, 2009  | By:                           | /s/      Alwin Tan                          |   |
|                          |                                    | Alwin      Tan                              |   |
|                          |                                    | Chief Executive Officer and      President  |   |

|        | By:   | /s/      Steven Wang                                            |   |
|--------|-----------------|-----------------------------------------------------------------|--------|
|   |            | Steven      Wang                                           |   |
|   |            | Vice President and Treasurer      Chief Financial Officer  |   |

----

| Number |   | Description                                                                                                                                                                |
|--------|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 31.1   |   | Certification      by Chief Executive Officer pursuant to Section 302 of the      Sarbanes-Oxley Act of 2002                                                          |
|   |   |                                                                                                                                                                       |
| 31.2   |   | Certification      by Chief Financial Officer pursuant to Section 302 of the      Sarbanes-Oxley Act of 2002                                                          |
|   |   |                                                                                                                                                                       |
| 32.1   |   | Certification      by Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as      adopted pursuant to Section 906 of the Sarbanes-Oxley Act of      2002 |
|   |   |                                                                                                                                                                       |
| 32.2   |   | Certification      by Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as      adopted pursuant to Section 906 of the Sarbanes-Oxley Act of      2002 |

----